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Abstract 
Background: The introduction of ART dramatically improved the survival and health quality of HIV-infected patients 
in the industrialized world; and the survival benefit of ART has been well studied too. However, in resource-poor 
settings, where such treatment was started only recently, limited data exist on treatment results. Since the military 
across most countries of the world had been identified as one of the eight vulnerable and most-at-risk sub-populations 
to HIV/AIDS, it is worthwhile undertaking studies in the area. 
Objectives: The objectives of this study were to estimate mortality rate and to identify survival predictors of patients 
taking ART based on data obtained from Armed Forces Teaching and General Hospital in Addis Ababa, Ethiopia. 
Methods: The records of 734 patients enrolled in the Armed Forces General Teaching Hospital in Addis Ababa 
between September 2003 and August 2007 were reviewed, and a retrospective cohort study conducted. The Kaplan-
Meier method and log-rank test were used to compare the survival experience of different categories of patients. The 
proportional hazards Cox regression model was employed to identify predictors of mortality. 
Results: Of the 734 included in the current study, 86 (11.7%) died during the first 12 months. Of these 28 (32.6%) 
deaths occurred within the first three months after initiation of ART; another 15 died in the following three months of 
follow up; that is to say a total of 43 (50%) deaths occurred within six months. In the last six months 43 patients died; 
that makes the remaining 50% of the total. The most important predictors of mortality at 0.05 level of significance 
were low CD4 cell count at baseline, employment status, functional status, WHO clinical stages III and IV, TB co-
infection, and opportunistic infections.   
Conclusion: Based on the finding of the study it can be concluded that a careful monitoring of patients with low CD4 
cell count, advanced WHO stages, history of opportunistic infections, ambulatory and bedridden functional status, co-
infection with TB and being employed/unemployed must be undertaken  in order to improve the survival of AIDS 
patients.  [Ethiop. J. Health Dev.  2012;26(3):186-192] 
 
Introduction 
AIDS is one of about 30 new infectious diseases, some of 
the others being Legionnaires’ disease, hepatitis C, 
bovine spongiform encephalopathy/variant Creutzfeld-
Jakob disease, several viral hemorrhagic fevers, and so 
on.  These have emerged as a result of profound world-
wide changes in human ecology (1). HIV infection leads 
to low levels of CD4+ T cells that in turn make the body 
susceptible to opportunistic infections. According to the 
UNAIDS report, it was estimated that 33.2 million 
people lived with the disease worldwide, and that AIDS 
killed an estimated 2.1 million people, including 330,000 
children. In 2008, an estimated 33.4 million people were 
living with HIV/AIDS worldwide; nearly 70% of these 
were found in sub-Saharan Africa (2). 
 
According the report by (3) nearly three million people in 
low- and middle-income countries were receiving ART 
treatment. That is a 10 fold jump when compared with 
some 300,000 taking Acquired immunodeficiency 
syndrome (AIDS) drugs in the year 2003. 
 
Survival patterns after HIV infection among African 
populations in the era before antiretroviral therapy (ART) 
form an important baseline for measuring future 
successes of treatment programs (4). Pre-antiretroviral 
therapy includes guidelines that attempt to address 
factors which are important in the holistic approach to 
patient management which could also influence the 
progression and outcome of disease including natural 
history of HIV infection, primary prophylaxis and 
immunization, nutrition, support and counseling (5). 
 
The provision of ART decreased morbidity and mortality 
in people living with HIV/AIDS. It can also reduce 
mother-to-child transmission of HIV. In July 2003, the 
government of Ethiopia adopted a policy of ARV drug 
supply and use, paving the way for additional initiatives 
that facilitate access to free and low-cost ARVs. The 
epidemic has rigorously affected different sectors of 
development and also challenged the severely 
constrained health care system of the country. In January 
2005 the government of Ethiopia launched the free ARV 
treatment initiative. About one million people were living 
with HIV in Ethiopia in the year 2008 (6). 
 
Using a cross-sectional national data (1) a very high ART 
dropout rate of about 20.7% has been documented, which 
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has been considered as a serious challenge to the national 
scaling up of the program. The study recommended that 
the extent of relevance of demographic, clinical and 
immunological correlates for survival in the Ethiopian 
setting had to be looked into. The finding in (7) based on 
the Ethiopian experience showed that patients who took 
HAART lived longer. 
 
Eight vulnerable and most-at-risk sub-populations to 
HIV/AIDS were identified (8). These are military and 
other uniformed forces; long-distance truck drivers and 
other transport workers; fishermen and fisherwomen; 
female sex workers; refugees and internally displaced 
persons; prisoners; and females affected by sexual and 
gender based violence.   
 
There is a claim that military personnel have a high risk 
of exposure to sexually transmitted diseases (STDs), 
including HIV/AIDS. In 1997, UNAIDS reported that 
sexually transmitted disease rates among armed forces 
are generally 2 to 5 times higher than in civilian 
populations; the difference could be even greater in times 
of conflict. By the same token, HIV/AIDS has been 
referred to as a pre-eminent security threat. The United 
Nations Security Council has met twice to discuss 
regional security instability in Africa due to the AIDS 
crisis.   
 
Military preparedness (effectiveness) has suffered as a 
result of HIV/AIDS, which has caused illness and death 
among army personnel. There is a psychological effect, 
due to the anxiety and discrimination associated with 
HIV, both from inside the army and from the families of 
army personnel in their own communities. There are 
additional burdens for the medical and social services in 
the army, including the cost of campaigns to prevent new 
infections, counseling services for groups at risk and for 
those infected, care for people living with HIV/AIDS, 
and social support measures for them and their families. 
Military planners have long recognized the link between 
soldiers' well-being and military effectiveness, 
particularly the health and fitness of troops before and 
during deployment (9).  
 
Based on a study in 21 countries of sub-Saharan Africa, it 
was concluded that HIV/AIDS prevalence in military 
(males) aged 15-24 was much higher than the general 
population of the same age and sex groups. The factors, 
which contribute to HIV infection and its transmission, 
were a direct result of the nature of military personnel 
(i.e., composed of young, male and sexually active 
individuals), long periods of being away from home and 
deployment to conflict zones (10).  
 
In 2000 the U.S. National Intelligence Council estimated 
the following HIV/AIDS military prevalence rates: 
Angola 40 to 60%, Eritrea 10%, DRC (Zaire) 40 to 60%, 
Nigeria 10 to 20%, Tanzania 15 to 30%, Cote d’Ivoire 10 
to 20%, and Congo Brazzaville 10 to 25%. Other recent 
estimates included the following: Lesotho 40%, Malawi 
50%, Zimbabwe 55%, Botswana 40%, Namibia 33%, 
Zambia 35%, and South Africa 21% (11). Though 
HIV/AIDS is undoubtedly a threat to individual security, 
the argument/notion that it risks national security, and 
further, international security, is unwarranted (12).   
 
Given the above background this study was undertaken 
with the two objectives: (i) to estimate mortality rate, and 
(ii) to identify predictors of the survival of HIV-infected 
army members and their dependants on ART based on 
data obtained from the Armed Forces Teaching and 
General Hospital in Addis Ababa, Ethiopia. It is hoped 
that the findings would be a contribution to research and 
of some use to practitioners and policy making.  
 
Methods 
This retrospective study used secondary data on HIV-
patients who enrolled in the Armed Forces General 
Teaching Hospital (AFGTH), Addis Ababa, Ethiopia. 
The hospital serves as a tertiary level teaching and 
referral hospital delivering health services to the defense 
forces, civilians in the Ministry of National Defense and 
their dependants, as well as public patients referred by 
other specialized hospitals. The ART clinic had its own 
separate facilities that include: pharmacy, dermatology, 
and ART laboratory units. A total of 734 patients who 
started ART between September 2003 and August 2007, 
were included for the study. These patients were 
followed up until August 2010.  
 
Patients were eligible for ART on the basis of the 2002 
World Health Organization (WHO) guidelines (WHO 
stage IV or CD4 cell count of lower than 200 cells/μL). 
Patients older than 15 years of age who never received 
any ART, and who started ART between September 2003 
and August 2007 at the ART clinic of AFGTH were 
considered. The investigators submitted the proposal to 
the Institutional Review Board Committee (IRBC) of 
AFGTH and obtained approval from the same. The 
hospital top management, upon receiving the 
recommendation of IRBC, gave its full consent for the 
study.  
  
The study was based on a review of the intake forms and 
follow-up cards of HIV patients on ART at AFGTH ART 
clinic. The forms were designed by the Federal Ministry 
of Health for uniformity for use in the country to 
document almost all relevant clinical and laboratory 
variables. Patients’ intake and follow up forms (cards) 
were cross examined for inconsistencies so that data 
quality issue could be ensured. The data were collected 
by a statistician and a public health officer, then coded, 
cleaned and analyzed using SPSS, SAS, and STATA 
software.  
 
The response variable “survival time” of HIV patients 
taking ART was defined as the length of time from ART 
start date until the date of death, measured in months. 
The predictor (covariates) variables included in the study 
were: age (in years), gender (male, female), marital status 
(never married, married, others), level of education (no 
education, primary, secondary and above), religion 
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(Muslim, Ethiopian orthodox, others), employment status 
(employed, not employed), opportunistic infections (no, 
yes), TB co-infection (no, yes), household size (one, two 
or more), number of rooms of residence (one, two or 
more), risk behavior (regular sexual partner, casual or 
both regular and casual sexual partner), substance 
(tobacco, alcohol, soft drugs) use (no, yes), functional 
status (working, ambulatory, bedridden), WHO clinical 
stages (stage I, II, III and IV), CD4 cells count, body 
weight (kg) and types of regimen (D4T-based,  AZT-
based).  
 
The statistical methods employed in this study were two: 
a non-parametric method called the Kaplan-Meier 
method (13) and a semi-parametric method known as 
Cox-proportional hazards regression model (14). For the 
theory and applications of these methods the interested 
reader can consult, among other sources (15) and (16).  
 
The Kaplan-Meier method is employed to estimate 
survival, and the associated log-rank is used for 
comparing estimated survival curves. The survivor 
function and hazard function are the two functions of 
central interest in describing and summarizing survival 
data. The basic quantity employed to describe time-to-
event phenomena is the survival function; that is, the 
probability of an individual surviving or being event-free 
beyond some plausible point in time. The hazard function 
describes the risk of an outcome (e.g., death, failure, 
hospitalization) in an interval after a specified time, 
conditional on the subject having survived to that 
specified time. The Cox model is a regression model that 
describes survival as a function of potential predictor 
variables. The parameters in the model were estimated by 
the partial maximum likelihood technique. Tests about 
the validity of the proportional hazards assumption of the 
model and overall goodness of fit have to be done to see 
if an adopted model is appropriate before it could be used 
as final. The proportional hazards assumption, which 
asserts that the hazard ratios should remain constant 
overtime, is vital to the interpretation and use of a fitted 
proportional hazards model. Plots of Cox-Snell and 
Schoenfeld residuals were used for the purpose of 
verifying the proportionality assumption. The likelihood 
ratio, score and Wald tests were used to test the goodness 




This study included 734 ART patients for whom data for 
the variables of interest (introduced above) were 
complete. The patients were followed up for a median of 
38.5 months. Of these 88.3% were censored and 11.7% 
death cases. The majority of patients were males (548); 
268 were never married; 381 had at least secondary 
school education; 632 were Ethiopian orthodox; 530 
were employed; 413 had a single room of residence; 479 
had at least two members in the household; 515 were 
naïve to substance use; 196 had bedridden functional 
status; 28 had regular sexual partners. The regimen d4T 
was frequently prescribed for 403 patients; 210 were in 
clinical stage IV. TB and opportunistic infections (OIs) 
were prevalent among 403 and 648 patients, respectively. 
The median age, CD4 count and weight of patients at 
start of ART were 34 years (inter-quartile range 29-40 
years), 83 cells/mm3 (inter-quartile range 36-139.25 
cells/mm3) and 53 kg (inter-quartile range  48-59 kg), 
respectively. The socio-economic and clinical 
characteristics of the patients are given in Table 1. 
 
Results of the Descriptive Analysis:  
Among the total of 734 study subjects, 86 (11.7%) died 
during the first 12 months. Of these 28 (32.6%) deaths 
occurred within the first three months after initiation of 
ART; another 15 died in the following three months of 
follow up; that is,  a total of 43 (50%) deaths occurred 
within six months. In the last six months, 43 patients 
died; that makes the remaining 50% of the total. 
 
The log-rank test was conducted to check for existence of 
any significant differences in survival experience 
between/among various levels of the categorical 
variables included in the study. The results in Table 2 
manifest no significant differences  among the categories 
of gender, marital status, religion, level of education, 
number of rooms within residence, risk behavior, ART 
regimen and substance use. On the other hand, the test 
confirmed significant differences in survival situation 
among different categories of employment status, 
household size, functional status, OIs, TB co-infection 
and WHO clinical stages. 
 
Results of the Proportional Hazards Cox Regression 
Analysis:  
The bivariate analysis indicated that not all 
predictors/variables were important to be included in the 
multivariable analysis stage on the basis of the 
selection/elimination process of the lax criterion at 25% 
level of significance. The covariates that were found to 
be statistically significant in the bivariate analysis were 
excluded successively in order of the magnitude in which 
they increase the log-likelihood. This process gave rise to 
a multiple proportional hazards Cox regression model 
that included only six covariates, namely employment 
status, functional status, WHO clinical stage, OIs, TB co-
infection, and CD4 cell count which were significant at 
5% level (Table 3). 
 
The Cox model of Table 3 shows that no covariates 
showed a trend/pattern with time, confirming that the 
hazard ratios remained constant over the study time. 
Also, the plots of the scaled Schoenfeld residuals of each 
covariate against log-time (not shown in the paper) were 
used to check if the assumption of proportional hazards 
was violated. The eight plots showed randomness; the 
smoothed plots approximated the horizontal line through 
zero reaffirming the fulfillment of proportional hazards 
assumption.  
 
The overall goodness of fit of the provisional/ 
preliminary model adopted so far (with the covariates in 
Table 3) was tested using the Cox-Snell residuals plot; 
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this test gave results that speak for the quality of model 
fit. In addition to these, the results of the likelihood ratio 
score and Wald tests for model goodness of fit confirmed 
that the model fit was significant at 5% level. Hence, the 
Cox model with those predictors/variables given in Table 
3 becomes the final model. 
 
Having established all the above statistical facts about the 
model we now provide the results based on the final 
model. It is worthwhile pointing out that the remaining 
covariates in the model had been controlled while 
presenting results about a single predictor variable.   
 
CD4 cell count: The estimated hazards ratio (HR) for a 
50 cells/mm3 increase in the baseline CD4 cell count was 
0.779 (with 95% CI:0.640 - 0.947) showing that the hazard rate for patients, whose CD4 cell count was 
higher by 50 cells/mm3 was about 22.1% lower than for 
patients in the next lower category.  
 
TB co-infection: The estimated HR for TB co-infected 
patients in relation to those who were not infected with 
TB was 1.734 (95% CI: 1.039 - 2.893). It means that the 
patients infected with TB had about 1.734 (or 73.4%) 
higher mortality than patients without TB infection.                                            
 
Opportunistic Infections: This study indicated that 
patients who suffered from OIs had nearly a 9-fold (or 
885%) risk of dying than those who were free of OIs 
(estimated HR 8.985 with 95% CI: 1.240-65.085).  
 
Employment status: The estimated HR for employed 
patients was 2.310 (95% CI: 1.248-4.275). This implies 
that employed HIV patients were 2.3-times more likely to 




Table 1: Socio-demographic and clinical characteristics of HIV patients under ART  
in the Armed Forces General Teaching Hospital, Addis Ababa, 2011(n=734). 
Covariates                 Category                     Censored (%)                  Dead               Total
Gender  Female 164 (88.2%) 22 186 
Male  484 (88.3%) 64 548 
 
Marital status                     
Never married 233 (86.9%) 35 268 
Married 317 (88.3%) 42 359 
Others 97 (91.5%) 9 106 
Religion Muslim 38 (82.6%) 8 46 
Coptic orthodox        560 (88.6%) 72 632 
Others                                           50 (89.3%) 6 56 
 
Education level 
No education 38 (88.4%) 5 43 
Primary 267 (86.1%)   43 310 
Secondary and  
above    
343 (90.0%) 38 381 
Employment status            Employed                      456 (86.0%) 74 530 
Not employed 192 (94.1%) 12 204 
No of Rooms Only one                       360 (87.2%)                       53              413 
2 rooms and more 288 (89.7%) 33                       321 
Household size Only one 217 (85.1%) 38                        255 
two and more               431 (90.0%) 48                        479 
Substance use No 452 (87.8%) 63 515 
Yes 196 (89.5%) 23 219 
 
Functional status                 
Working                       261 (95.6%) 12 273 
Ambulatory                  237 (89.4%) 28 265 
Bedridden                    150 (76.5%) 46 196 
 
Risk behavior                      
Regular                         24 (85.7%) 4 28 
Casual or both 
regular and casual 
624 (88.4%) 82 706 
TB co-infection                    No 311 (94.0%)                      20 331 
Yes 337 (83.6%)                     66 403 
ART regimen D4T-based 352 (87.3%) 51 403 
AZT-based 296 (89.4%) 35 331 
OIs No 85 (98.8%) 1 86 
Yes 563 (86.9%) 85 648 
WHO clinical stage Stage I and II 199 (99.0%) 2 201 
Stage III 286 (88.5%) 37 323 
Stage IV 163 (77.6%) 47 210 
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Table 2: Results of the bivariate Cox regression analysis - HIV patients under ART  
in the Armed Forces General Teaching Hospital, Addis Ababa, 2011(n=734). 
Covariates                 Sig. Hazard ratio 
Gender                0.921    1.025         
Marital status                                       0.285  
Married                  0.122 1.782 
Never married         0.297 1.466 
Religion                                              0.364  
Muslim                   0.213 1.963 
Coptic orthodox       0.662 1.205 
Education                                            0.100                      
Primary                   0.698 1.201 
Secondary and above secondary   0.535 0.744 
Employment  status           0.003 2.499         
Room                       0.153 1.373         
Household size                         0.017 1.684 
Risk                          0.628 1.282          
Substance                  0.559 1.153          
Functional status                                   0.000  
Ambulatory               0.005 2.650 
Bedridden                  0.000 6.952 
WHO clinical stage                              0.000  
Stage III 0.000 12.688 
Stage IV 0.000 27.217 
OIs 0.014 11.740      
TB co-infection 0.000 2.932        
Regimen 0.206 1.321         
Age 0.129 1.020         
Weight 0.001 0.959        
CD4 Count 0.000 0.989        
 
 
Table 3: Summary statistics - HIV patients under ART in the Armed Forces General  





Estimated 95% CI for the hazard  
                      Ratio 
   Lower Upper 
Employment status 0.008 2.310 1.248 4.275 
Functional Status 0.001       
Ambulatory 0.044 2.011 1.018 3.973 
Bedridden 0.000 3.358 1.734 6.500 
WHO Stage  0.000       
Stage III 0.008 7.052 1.677 29.658 
Stage IV 0.001 12.640 3.003 53.199 
OIs 0.030 8.985 1.240 65.085 
TB co-infection 0.035 1.734 1.039 2.893 
CD4 count 0.017 0.779 0.640 0.947 
 
WHO clinical stages: The estimated HRs and CIs for 
WHO levels III and IV, respectively, were 7.052 (95% 
CI: 1.677-29.658) and 12.640 (95% CI: 3.003-53.199). 
The interpretation is that: patients in stage III and IV 
were, respectively, 7-fold and 12.64-times at risk of 
dying than patients in stages I and II. 
 
Functional status: The estimated HRs and CIs of HRs for 
ambulatory and bedridden patients were 2.011 (95% CI: 
1.018-3.973) and 3.358 (95% CI: 1.734-6.500), 
respectively. The implication is that ambulatory and 
bedridden patients, respectively, were twice and 3.36-
times at higher risks of death than patients who were 
actively engaged in work. 
 
Discussion  
In this study, baseline CD4 cell count, TB co-infection, 
employment status, opportunistic infections, functional 
status and WHO clinical stage were found to be 
statistically significant determinants of survival longevity 
of the patients on ART. The remaining part of this 
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section relates the results of the current study with the 
findings of similar research undertakings.   
 
It is to be expected that baseline CD4 cell count would 
have an impact on health status, and therefore, mortality 
of patients on ART. In this connection we point out the 
research findings of six studies done in sub-Saharan 
countries. Of these, the findings in (17, 18, 19) identified 
low CD4 cell count as a determining factor of death 
while (20, 21, 22, 23) showed that CD4 count was a 
laboratory predictor of mortality in the sense that higher 
CD4 count is associated with longer survival experience. 
Our findings concur with the findings of the above 
sources. 
 
The impact of TB-confection on the survival longevity of 
HIV-positive people could only be negative.  According 
to (24) and (25), TB co-infection was found to be a cause 
of high mortality of HIV patients. This study arrived at 
the same conclusion. 
 
Three studies in sub-Saharan Africa showed that OIs 
were found to be common causes of death among 
patients under ART (18, 26, 27). The current study 
established a similar finding.   
 
In the two studies (28, 29) unemployment was found to 
be a risk factor contributing to mortality of HIV patients;  
being employed contributed to longer survival among 
HIV-patients taking ART.  Contrary to the above our 
results concluded the opposite.  
 
It is a known fact that WHO clinical stages have direct 
association with the health status of HIV patients. Our 
finding showed that that the two advanced WHO clinical 
stages III and IV were found to be independent markers 
of mortality among HIV-patients on ART. This 
conclusion was in agreement with the findings in (18, 19, 
30).  
 
Functional status (remaining active, inactive or being 
ambulatory) has an association with the wellbeing an 
individual, whether healthy or not healthy. In the case of 
HIV patients on ART the findings, according to (31, 32), 
showed that reduced ability to perform activities of daily 
living (ADL) led to shorter survival. The findings in (21) 
showed that ambulatory and bedridden patients, 
respectively, were 82.5% and nearly four-and-half times 
more likely to die compared to those engaged in active 
working. The current study revealed that ambulatory and 
bedridden patients were twice and nearly three-and-half 
times, respectively, at higher risks of death than active 
patients.  
 
to (31, 32) reduced ability to perform self-sufficiency in 
activities of daily living (ADL) led to shorter survival. 
The findings in (21) showed that ambulatory and 
bedridden patients, respectively, were 82.5% and nearly 
four-and-half times more likely to die compared to those 
engaged in active working. The current study revealed 
that ambulatory and bedridden patients were twice and 
nearly three-and-half times, respectively, at higher risks 
of death than active patients.  
 
This study revealed gender, marital status, religion, level 
of education, number of rooms in a residence, risk 
behavior, ART regimen and substance use as being 
statistically non-significant covariates of survival of HIV 
infected patients under ART. The paramount justification 
for the non-significance of these covariates may be due to 
the respective small number of cases in addition to the 
prevailing bias in the secondary data.  
 
Conclusion and Recommendations:  
This retrospective study gave an insight into survival and 
its determinants in an army hospital setting in Ethiopia. It 
revealed that the estimated mean survival time of patients 
under the study was 72 months.  High mortality occurred 
in the earlier months of treatment.  Advanced WHO 
clinical stages (III and IV), lower CD4 cell count (<50 
cells/mm3), TB co-infection, history of OIs, patients in 
bedridden and ambulatory functional status were found to 
be strongly related to the mortality of HIV-infected 
patients that were included in this study. 
 
The results suggested that, since lower CD4 cell count, 
being bedridden and WHO clinical stages are markers of 
the progression of the disease, patients should be 
informed about their health status related to the medical 
diagnostic results. Such information could give patients 
time to make their minds and get prepared to receive 
ART. The high rate of early mortality had to be 
addressed by increasing the availability of early HIV 
diagnosis and treatment services. Since employed                                                                 
patients experienced a high level of mortality due 
attention must be given to create favorable conditions at 
their work places. It could be that the employment 
brought with it stress and exhaustion thereby contributing 
to shortening of their survival status.  
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